Leidos (LDOS) Stock Gets Fair Value Trim As Health Concerns Temper Analyst Views

The fair value estimate for Leidos Holdings has been cut slightly from US$157.73 to US$151.73 per share, a reduction of about 3.8%. This shift aligns with recent analyst debates that weigh stronger contributions from defense, intelligence, digital, and homeland work against a more challenging environment for the Health segment and its impact on valuation support. As you read on, you will see how this evolving narrative may influence the way you track Leidos Holdings from here. Analyst Price...